iSonea picks manufacturing partner for AirSonea
iSonea (ASX:ISN) has selected Hong Kong-based Refined Manufacturing to produce its AirSonea mobile wheeze monitoring device.
iSonea, which plans to launch the product in the Australian market in September, had already engaged Refined to produce several prototype AirSonea units. Refined will now scale up to prepare for commercial manufacturing.
“Finding a source with extensive experience and scalability to manufacture products that are smart-phone compatible was a crucial step in our transition to commercial production,” iSonea CEO Michael Thomas said.
AirSonea will allow patients to track and share acoustic respiratory monitoring data via smart phones.
Last week, iSonea released the results of a survey suggesting that 80% of Australian GPs surveyed would recommend AirSonea to their patients.
The company also recently unveiled AsthmaSense cloud, a cloud-based asthma monitoring tool.
iSonea shares were trading 8.11% higher at $0.40 as of around 1.30 pm on Wednesday.
Oxytocin analogue treats chronic abdominal pain
Researchers have developed a new class of oral painkillers to suppress chronic abdominal pain,...
'Low-risk' antibiotic linked to rise of dangerous superbug
A new study has challenged the long-held belief that rifaximin — commonly prescribed to...
Robotic hand helps cultivate baby corals for reef restoration
The soft robotic hand could revolutionise the delicate, labour-intensive process of cultivating...
